Page last updated: 2024-08-24

fluorodeoxyglucose f18 and mirabegron

fluorodeoxyglucose f18 has been researched along with mirabegron in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	3 (60.00)	2.80

Authors

Authors	Studies
Constantinescu, CC; Mirbolooki, MR; Mukherjee, J; Pan, ML; Schade, KN	1
Chatman, K; Cypess, AM; Doria, A; English, J; Franquet Elía, E; Kahn, PA; Kessler, SH; Kolodny, GM; Roberts-Toler, C; Trauger, SA; Weiner, LS	1
Ikeuchi, T; Kikuchi, R; Okuyama, C	1
Brychta, RJ; Chen, KY; Cypess, AM; Israni, NS; Jiang, A; Lea, HJ; Lentz, TN; Pierce, AE	1
Suthar, PP; Virmani, S	1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and mirabegron

Article	Year
Activation of human brown adipose tissue by a β3-adrenergic receptor agonist. Cell metabolism, 2015, Jan-06, Volume: 21, Issue:1 Topics: Acetanilides; Adipose Tissue, Brown; Adrenergic Agonists; Basal Metabolism; Chromatography, High Pressure Liquid; Fluorodeoxyglucose F18; Glucose; Humans; Male; Obesity; Positron-Emission Tomography; Receptors, Adrenergic, beta-3; Tandem Mass Spectrometry; Thiazoles; Tomography, X-Ray Computed; Young Adult	2015

Article

Year

Activation of human brown adipose tissue by a β3-adrenergic receptor agonist.

Cell metabolism, 2015, Jan-06, Volume: 21, Issue:1

Topics: Acetanilides; Adipose Tissue, Brown; Adrenergic Agonists; Basal Metabolism; Chromatography, High Pressure Liquid; Fluorodeoxyglucose F18; Glucose; Humans; Male; Obesity; Positron-Emission Tomography; Receptors, Adrenergic, beta-3; Tandem Mass Spectrometry; Thiazoles; Tomography, X-Ray Computed; Young Adult

2015

Other Studies

4 other study(ies) available for fluorodeoxyglucose f18 and mirabegron

Article	Year
Enhancement of 18F-fluorodeoxyglucose metabolism in rat brain frontal cortex using a β3 adrenoceptor agonist. Synapse (New York, N.Y.), 2015, Volume: 69, Issue:2 Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Blood-Brain Barrier; Dioxoles; Fluorodeoxyglucose F18; Frontal Lobe; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Thiazoles; Tomography, X-Ray Computed	2015
FDG Uptake in Brown Adipose Tissue Activated by a β3-Adrenergic Receptor Agonist Prescribed for Overactive Bladder. Clinical nuclear medicine, 2020, Volume: 45, Issue:8 Topics: Acetanilides; Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adrenergic Agonists; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles; Urinary Bladder, Overactive	2020
Activating Human Adipose Tissue with the β3-Adrenergic Agonist Mirabegron. Methods in molecular biology (Clifton, N.J.), 2022, Volume: 2448 Topics: Acetanilides; Adipose Tissue, Brown; Adrenergic beta-Agonists; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Thiazoles	2022
Intense Brown Fat Uptake at FDG PET/CT Induced by Mirabegron. Radiology. Imaging cancer, 2023, Volume: 5, Issue:4 Topics: Adipose Tissue, Brown; Fluorodeoxyglucose F18; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023